NCT05432804 2026-03-18
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
National Cancer Institute (NCI)
Phase 1/2 Suspended
Clinical Trials
11 trialsNCT06934928 2026-03-05
Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)
Massachusetts General Hospital
Phase NA Suspended
NCT03994796 2026-03-04
Genetic Testing in Guiding Treatment for Patients With Brain Metastases
Alliance for Clinical Trials in Oncology
Phase 2 Suspended
NCT07224503 2026-02-23
C-SMART vs BE Well for Patients With Brain Tumors
Virginia Commonwealth University
Phase NA Suspended
NCT05428852 2026-02-10
Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases
Ohio State University Comprehensive Cancer Center
Phase NA Suspended
NCT07301268 2026-02-03
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Mayo Clinic
Phase 2 Suspended
NCT04810871 2026-01-30
Surgical Resection of Latent Brain Tumors Prior to Recurrence
Mayo Clinic
Phase NA Suspended
NCT04309552 2026-01-27
Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma
Weill Medical College of Cornell University
Phase 1 Suspended
NCT07353229 2026-01-23
68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma
Thomas Jefferson University
Phase 1 Suspended
NCT04217525 2026-01-20
DSOS
Duke University
Suspended
NCT04677049 2026-01-02
Study of Niacin in Glioblastoma
AHS Cancer Control Alberta
Phase 1/2 Suspended